Luy Ing Yan

Director/Board Member presso MICROPORT CARDIOFLOW MEDTECH CORPORATION

Patrimonio netto: 83 183 $ in data 31/03/2024

43 anni

Health Technology

Consumer Services

Profilo

Luy Ing Yan is currently an Executive Director at Shanghai MicroPort CardioFlow Medtech Co., Ltd.
and an Executive Director & VP-Regulatory Affairs at MicroPort CardioFlow Medtech Corp.
She completed her undergraduate and graduate degrees at Capital Medical University in 2004 and 2012, respectively.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
MICROPORT CARDIOFLOW MEDTECH CORPORATION 0.02%	11/07/2023	576 137 ( 0.02% )	83 183 $	31/03/2024

Posizioni attive di Luy Ing Yan

Società	Posizione	Inizio
MICROPORT CARDIOFLOW MEDTECH CORPORATION	Director/Board Member	29/09/2020
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023.	Director/Board Member	29/09/2020

Tutte le posizioni attive di Luy Ing Yan

Formazione di Luy Ing Yan

Capital Medical University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Luy Ing Yan

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
MICROPORT CARDIOFLOW MEDTECH CORPORATION	Health Technology

Aziende private	1
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023.	Health Technology